Explosion of Publications, Clinical Trials Driving Growth Of Biomarkers Technology

Increased Research, Dialogue and Collaborations Among Stakeholders Moving Biomarkers Market Forward

March 05, 2021

Our bodies give us all the clues we need—the trick is reading them correctly.

Biomarkers can be thought of as biological indicators of health and disease. They can be detected visually—with or without imaging—or with a test.

The global biomarkers market is growing at a significant pace, thanks to new applications of biomarkers as essential tools in drug discovery and development, according to the BCC Research report, Biomarkers: Technologies and Global Markets.

Enhancements in existing analytical methods and developments of new, sophisticated and sensitive multiplex methods in gene expression analysis, proteomics, metabolomics and transcriptomics are driving this market.

Development of multi-biomarker assays and novel immunoassays, as well as multi-modal imaging and mass spectrometry methods, are further driving market growth.

Report Highlights

• The global market of biomarker technologies is projected reach $92.1 billion in 2025, up from $43.3 billion in 2020 and rising at a CAGR of 16.3% from 2020-2025.
• Genomics is the fastest growing biomarker technology, expected to rise at a CAGR of 16.8% through 2025.
• Analysis of key market players: Abbott Laboratories, Johnson & Johnson and Novartis.

Explore the full report here: https://www.bccresearch.com/market-research/biotechnology/biomarkers-markets-report.html

Biomarkers: Technologies and Global Markets( BIO061F )
Publish Date: Mar 2021    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.